- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CGM's Impact on Clinical Inertia
This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss how continuous glucose monitoring (CGM) adoption impacts clinical inertia and supports earlier therapeutic interventions across different patient populations, highlighting measurable improvements in patient outcomes, such as glycemic control, hemoglobin A1c (HbA1c) levels, hypoglycemic events, and quality of life.
EP: 1.CGM: Redefining Type 2 Diabetes Management
EP: 2.Key Benefits of CGM Technology
EP: 3.CGM's Impact on Clinical Inertia
EP: 4.CGM vs Traditional Monitoring
EP: 5.Understanding CGM Metrics
EP: 6.Health Care System Integration
EP: 7.CGM Coverage and Access
EP: 8.Implementation Barriers
EP: 9.Overcoming Access Challenges
EP: 10.Adoption Strategies
EP: 11.The Metro Nashville Public Schools Initiative
EP: 12.Health Care Quality Impact
EP: 13.Population Outcomes and Return on Value With CGMs
EP: 14.Long-Term Outcomes Assessment
EP: 15.Closing Perspectives
Video content above is prompted by the following:
- How does CGM adoption impact clinical inertia and support earlier therapeutic interventions across different patient populations?
- What measurable improvements have been seen with CGMs in patient outcomes (eg, glycemic control, HbA1c levels, hypoglycemic events, quality of life)?
- Because each segment is considered a separate entity, each group of discussion questions should reset with No. 1 if using numbers.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Affirmative Action Repeal Decreases Minority Acceptance and Matriculation in Medical Schools
August 27th 2025Medical school application and matriculation rates decreased for underrepresented racial and ethnic minorities in medicine after the 2023 Supreme Court affirmative action repeal.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
For Better Cancer Outcomes, It’s All About Access
August 21st 2025New drugs aren't the only advances in oncology. Innovation includes collaboration between to remove barriers to remove barriers to care, according to experts who gathered for a session of the Institute for Value-Based Medicine in Arlington, Virginia.
Read More
